课题基金 / 基金详情

项目摘要

项目成果

Frederick M Ausubel的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Plants and animals respond to PAMPs (pathogen-associated molecular patterns) that are indicative of pathogens. Oligogalacturonides (OGs), plant cell wall fragments generated by pathogen polygalacturonases, function as a PAMP in Arabidopsis thaliana. We hypothesize that OG-activated innate immune response pathways are among the most ancient and are most similar to so-called "Toll-like" innate immune signaling pathways in animals. An important unanswered question in plant innate immunity is how PAMP-activated pathways relate to signaling pathways that respond to pathogen-specific signals. The specific aims are designed to further investigate Arabidopsis OG signaling pathway(s) and to identify Pseudomonas syringae Type III effectors that disrupt these pathways. We also hypothesize those Og-activated genes that encode cytochrome P450s function in the biosynthesis of antimicrobial compounds. We have found that some P. syringae strains elicit the exudation of antimicrobial secondary products from Arabidopsis roots, but that P. syringae strain DC3000 blocks this exudation in a process that involves Type III secretion. This is a novel system to study how PAMP-elicited innate immune responses confer basal resistance and how pathogens overcome this resistance. There are five aims. We propose to use a variety of molecular genetic and genomic methods to determine how the OG signaling pathway intersects with other defense response signaling pathways. We will use forward genetic and genomic analyses to identify components of OG signaling pathway(s). We will identify P. syringae type III effectors that block OG-activated signaling pathways and/or the synthesis/exudation of antimicrobial compounds by roots. We will identify signaling pathways that lead to the biosynthesis of antimicrobial compounds. Finally, we will enter the data from this project into IMDS, a public, web-accessible relational database.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
First-in-class small molecule therapeutics to enhance gut barrier function in inflammatory bowel disease
  • 批准号:
    10251430
  • 项目类别:
  • 资助金额:
    $25.12万
  • 财政年份:
    2021
  • 负责人:
    Frederick M Ausubel
  • 依托单位:
First-in-class small molecules that enhance lung barrier function during acute respiratory distress syndrome (ARDS) as potential therapeutics for COVID-19
  • 批准号:
    10254996
  • 项目类别:
  • 资助金额:
    $25.0万
  • 财政年份:
    2021
  • 负责人:
    Frederick M Ausubel
  • 依托单位:
Discovering Novel Therapeutics for Myotonic Dystrophy Type 1 (DM1)
  • 批准号:
    9409067
  • 项目类别:
  • 资助金额:
    $15.0万
  • 财政年份:
    2017
  • 负责人:
    Frederick M Ausubel
  • 依托单位:
Identifying novel anti-infectives by high through-put screening in whole animals
  • 批准号:
    7764005
  • 项目类别:
  • 资助金额:
    $84.17万
  • 财政年份:
    2009
  • 负责人:
    Frederick M Ausubel
  • 依托单位:
海外基金